Tiziana Life Sciences announces $4 million grant awarded by NIH to study anti-CD3 in Alzheimer’s disease: New York Saturday, September 21, 2024, 14:00 Hrs [IST] Tiziana Life Sci ...

Rice University and Baylor College of Medicine  have received $2.8 million in funding from the National Heart, Lung, and Blood Institute (NHLBI), a division of the National ...

Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, ...

Rice University and Baylor College of Medicine have received $2.8 million in funding from the National Heart, Lung, and Blood ...

Analyst Cory Jubinville, PhD of LifeSci Capital maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report), retaining the ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and ...

Initiated by the Global Sepsis Alliance in 2012, World Sepsis Day falls on Sept 13 each year. Sepsis remains a global health-care problem that affects all age groups. The extrapolated annual incidence ...

The EU’s revised MDR 2017/745 was introduced in 2017 and became fully applicable to all medical devices on 27 May 2024.

Mallinckrodt plc, a global specialty pharmaceutical company, announced that the THERAKOS™ CELLEX™ Photopheresis System has ...

The Cambridge company was founded as an RNA-focused spinout of Beam Therapeutics. The startup is initially focused on the ...

By combining engineering strategies for enhanced mucosal delivery with a better understanding of immune mechanisms in the NALT and BALT, we hope to illustrate the potential of these mucosal sites as ...

Expressed on the surface of CD8 + T cells, the CD8 co-receptor is a key component of the T cells that contributes to antigen recognition, immune cell maturation, and immune cell signaling. While CD8 ...